FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982203495> ?p ?o ?g. }

• W2982203495 abstract "Abstract Background In the DISCOVER PrEP trial, emtricitabine/tenofovir alafenamide (F/TAF) was noninferior to emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV prevention. Here, we report on the renal outcomes of F/TAF and F/TDF among all DISCOVER participants and in those on baseline F/TDF PrEP who were randomized to F/TAF. Methods In total, 5387 men who have sex with men (MSM) and transgender women (TGW) at risk for HIV were randomized 1:1 to receive blinded F/TDF or F/TAF taken once daily (full cohort). Of these, 905 were on F/TDF PrEP at enrollment; of whom, 465 were randomized to F/TAF. Renal function and safety assessments included urinalysis (UA), estimated glomerular filtration rate (eGFRCG), urine protein:creatinine (Cr) ratio (UPCR), markers of proximal tubular function (β2-microglobulin:Cr ratio [β2M:Cr] and retinol-binding protein:Cr ratio [RBP:Cr]) and investigator-reported renal adverse events (AEs). Week 48 data are presented. Results In the full cohort, F/TAF was associated with more favorable changes in eGFRCG, β2M:Cr, and RBP:Cr compared with F/TDF (Table 1). Treatment-emergent proteinuria by UA was more common with F/TDF than F/TAF (24.3% vs. 21.3% P = 0.009), as were treatment-emergent elevations in UPCR >200 mg/g (35 [1.5%] vs. 16 [0.7%], P = 0.005). Compared with F/TDF, participants taking F/TAF had numerically fewer study drug-related renal AEs, severe study drug-related renal AEs, and discontinuations due to renal AEs (Table 2). Proximal renal tubulopathy (Fanconi syndrome) was reported in one participant in the F/TDF arm and none in the F/TAF arm. In participants on F/TDF PrEP at enrollment who were randomized to F/TAF, statistically significant increases in eGFRCG were apparent as early as week 4 (Table 1 and Figure 1), as were decreases in tubular proteinuria (Table 1). Renal biomarker changes in PrEP-naïve participants mirrored those in the full cohort. Conclusion Through 48 weeks, MSM and TGW taking F/TAF for PrEP had significantly better measures of renal function and fewer study-drug-related renal AEs compared with those taking F/TDF; switching from F/TDF to F/TAF was associated with improvements in eGFRCG and tubular function biomarkers. F/TAF for PrEP is effective and has a superior renal safety profile compared with F/TDF. Disclosures All Authors: No reported Disclosures." @default.
• W2982203495 created "2019-11-01" @default.
• W2982203495 creator A5003793199 @default.
• W2982203495 creator A5008971359 @default.
• W2982203495 creator A5019635523 @default.
• W2982203495 creator A5022831220 @default.
• W2982203495 creator A5023067810 @default.
• W2982203495 creator A5024710603 @default.
• W2982203495 creator A5033836920 @default.
• W2982203495 creator A5062954288 @default.
• W2982203495 creator A5064101905 @default.
• W2982203495 creator A5068297574 @default.
• W2982203495 creator A5073100933 @default.
• W2982203495 creator A5073519594 @default.
• W2982203495 creator A5076529428 @default.
• W2982203495 creator A5085812235 @default.
• W2982203495 creator A5091909943 @default.
• W2982203495 date "2019-10-01" @default.
• W2982203495 modified "2023-10-02" @default.
• W2982203495 title "1962. Renal Outcomes for Participants Taking F/TAF vs. F/TDF for HIV PrEP in the DISCOVER Trial" @default.
• W2982203495 doi "https://doi.org/10.1093/ofid/ofz359.139" @default.
• W2982203495 hasPublicationYear "2019" @default.
• W2982203495 type Work @default.
• W2982203495 sameAs 2982203495 @default.
• W2982203495 citedByCount "2" @default.
• W2982203495 countsByYear W29822034952020 @default.
• W2982203495 countsByYear W29822034952021 @default.
• W2982203495 crossrefType "journal-article" @default.
• W2982203495 hasAuthorship W2982203495A5003793199 @default.
• W2982203495 hasAuthorship W2982203495A5008971359 @default.
• W2982203495 hasAuthorship W2982203495A5019635523 @default.
• W2982203495 hasAuthorship W2982203495A5022831220 @default.
• W2982203495 hasAuthorship W2982203495A5023067810 @default.
• W2982203495 hasAuthorship W2982203495A5024710603 @default.
• W2982203495 hasAuthorship W2982203495A5033836920 @default.
• W2982203495 hasAuthorship W2982203495A5062954288 @default.
• W2982203495 hasAuthorship W2982203495A5064101905 @default.
• W2982203495 hasAuthorship W2982203495A5068297574 @default.
• W2982203495 hasAuthorship W2982203495A5073100933 @default.
• W2982203495 hasAuthorship W2982203495A5073519594 @default.
• W2982203495 hasAuthorship W2982203495A5076529428 @default.
• W2982203495 hasAuthorship W2982203495A5085812235 @default.
• W2982203495 hasAuthorship W2982203495A5091909943 @default.
• W2982203495 hasBestOaLocation W29822034951 @default.
• W2982203495 hasConcept C126322002 @default.
• W2982203495 hasConcept C2776939746 @default.
• W2982203495 hasConcept C2776983459 @default.
• W2982203495 hasConcept C2779496540 @default.
• W2982203495 hasConcept C3013748606 @default.
• W2982203495 hasConcept C512399662 @default.
• W2982203495 hasConcept C71924100 @default.
• W2982203495 hasConceptScore W2982203495C126322002 @default.
• W2982203495 hasConceptScore W2982203495C2776939746 @default.
• W2982203495 hasConceptScore W2982203495C2776983459 @default.
• W2982203495 hasConceptScore W2982203495C2779496540 @default.
• W2982203495 hasConceptScore W2982203495C3013748606 @default.
• W2982203495 hasConceptScore W2982203495C512399662 @default.
• W2982203495 hasConceptScore W2982203495C71924100 @default.
• W2982203495 hasLocation W29822034951 @default.
• W2982203495 hasLocation W29822034952 @default.
• W2982203495 hasOpenAccess W2982203495 @default.
• W2982203495 hasPrimaryLocation W29822034951 @default.
• W2982203495 hasRelatedWork W1964217313 @default.
• W2982203495 hasRelatedWork W2061231224 @default.
• W2982203495 hasRelatedWork W2076365181 @default.
• W2982203495 hasRelatedWork W2186174256 @default.
• W2982203495 hasRelatedWork W2270738397 @default.
• W2982203495 hasRelatedWork W2319850419 @default.
• W2982203495 hasRelatedWork W2327535499 @default.
• W2982203495 hasRelatedWork W2582571042 @default.
• W2982203495 hasRelatedWork W2596552147 @default.
• W2982203495 hasRelatedWork W2727608564 @default.
• W2982203495 hasRelatedWork W2762030468 @default.
• W2982203495 hasRelatedWork W2764064986 @default.
• W2982203495 hasRelatedWork W3018292028 @default.
• W2982203495 hasRelatedWork W3044188507 @default.
• W2982203495 hasRelatedWork W3111380974 @default.
• W2982203495 hasRelatedWork W3121008081 @default.
• W2982203495 hasRelatedWork W3146444011 @default.
• W2982203495 hasRelatedWork W3155004931 @default.
• W2982203495 hasRelatedWork W3155646138 @default.
• W2982203495 hasRelatedWork W3190984309 @default.
• W2982203495 isParatext "false" @default.
• W2982203495 isRetracted "false" @default.
• W2982203495 magId "2982203495" @default.
• W2982203495 workType "article" @default.